Tiny Hearts is developing affordable, solar-powered phototherapy devices to treat neonatal jaundice, a leading cause of infant mortality in Nigeria. With fewer than 15 percent of Nigerians having access to reliable electricity, conventional phototherapy units remain inaccessible for many hospitals. Tiny Hearts addresses this gap through locally manufactured Crib A’Glow phototherapy units, which provide life-saving treatment even in off-grid settings.
The company also supplies a complementary suite of neonatal tools, including the Bili-Jaundice Ruler (avisual assessment tool), Photo-care blindfolds (for eye protection during treatment), and Yello-Baby — a digital skin-tone analysis device for precise jaundice detection. Since 2017, Tiny Hearts has treated over 1 million babies and trained 4,000 healthcare workers, from pediatric nurses to traditional birth attendants, in early jaundice detection and safe phototherapy use
